Scipher Medicine Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 116

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.85M

  • Investors
  • 17

Scipher Medicine General Information

Description

Developer of a precision medicine platform designed to determine which drug will work better for each patient going through an autoimmune disease. The company's platform identifies which drug will work based on the patient's fundamental disease biology and the data from molecular signature tests and not based on symptoms, disease classification, or medical bias, enabling physicians to ensure that optimal treatment is prescribed from day one.

Contact Information

Formerly Known As
DZZCOM
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500 Totten Pond Road
  • 6th Floor
  • Waltham, MA 02451
  • United States
+1 (781)
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 500 Totten Pond Road
  • 6th Floor
  • Waltham, MA 02451
  • United States
+1 (781)

Scipher Medicine Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scipher Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 30-Jul-2024 $5.85M Completed Generating Revenue
6. Later Stage VC (Series D) 24-Feb-2022 Completed Generating Revenue
5. Later Stage VC (Series C) 12-Mar-2021 Completed Generating Revenue
4. Later Stage VC 19-Feb-2020 Completed Generating Revenue
3. Early Stage VC (Series A) 09-Aug-2018 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2018 $575K Completed Generating Revenue
1. Seed Round 06-Nov-2016 $575K $575K Completed Generating Revenue
To view Scipher Medicine’s complete valuation and funding history, request access »

Scipher Medicine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B
Series A 1,216,331 $0.001000 8% $7.75 $7.75 1x $7.75 9.46%
Seed 676,128 $0.001000 8% $2.4 $2.4 1x $2.4 5.26%
To view Scipher Medicine’s complete cap table history, request access »

Scipher Medicine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision medicine platform designed to determine which drug will work better for each patient going thro
Decision/Risk Analysis
Waltham, MA
116 As of 2024

McLean, VA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Scipher Medicine Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perthera Venture Capital-Backed McLean, VA
ImmuneID Venture Capital-Backed Waltham, MA
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
Ambry Genetics Private Equity-Backed Aliso Viejo, CA
Caris Life Sciences Private Equity-Backed Irving, TX
You’re viewing 5 of 22 competitors. Get the full list »

Scipher Medicine Patents

Scipher Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3223856-A1 Methods and systems for therapy monitoring and trial design Pending 22-Jun-2021
CA-3223699-A1 Methods and systems for personalized therapies Pending 22-Jun-2021
AU-2022298652-A1 Methods and systems for personalized therapies Pending 22-Jun-2021
AU-2022300269-A1 Methods and systems for therapy monitoring and trial design Pending 22-Jun-2021
GB-2624985-A Methods and systems for personalized therapies Pending 22-Jun-2021 G16H50/20
To view Scipher Medicine’s complete patent history, request access »

Scipher Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scipher Medicine Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
bpd partners Family Office Minority
Cobalt Ventures (Kansas City) Corporate Venture Capital Minority
Cowen Healthcare Investments Venture Capital Minority
Hitachi Ventures Corporate Venture Capital Minority
Laurion Capital Management Hedge Fund Minority
You’re viewing 5 of 17 investors. Get the full list »

Scipher Medicine Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CrossBridge Health 19-Oct-2022 Other Healthcare Technology Systems
To view Scipher Medicine’s complete acquisitions history, request access »

Scipher Medicine Subsidiaries (1)

Company Name Industry Location Founded
CrossBridge Health Other Healthcare Technology Systems Wayne, PA
To view Scipher Medicine’s complete subsidiaries history, request access »

Scipher Medicine FAQs

  • When was Scipher Medicine founded?

    Scipher Medicine was founded in 2015.

  • Where is Scipher Medicine headquartered?

    Scipher Medicine is headquartered in Waltham, MA.

  • What is the size of Scipher Medicine?

    Scipher Medicine has 116 total employees.

  • What industry is Scipher Medicine in?

    Scipher Medicine’s primary industry is Decision/Risk Analysis.

  • Is Scipher Medicine a private or public company?

    Scipher Medicine is a Private company.

  • What is Scipher Medicine’s current revenue?

    The current revenue for Scipher Medicine is .

  • How much funding has Scipher Medicine raised over time?

    Scipher Medicine has raised $232M.

  • Who are Scipher Medicine’s investors?

    bpd partners, Cobalt Ventures (Kansas City), Cowen Healthcare Investments, Hitachi Ventures, and Laurion Capital Management are 5 of 17 investors who have invested in Scipher Medicine.

  • Who are Scipher Medicine’s competitors?

    Perthera, ImmuneID, Personal Genome Diagnostics, Ambry Genetics, and Caris Life Sciences are some of the 22 competitors of Scipher Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »